Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Year Efficacy Study of Fluzone High-Dose Trivalent Vaccine Compared With Fluzone® Vaccine In Adults ≥ 65 Years of Age

NCT00976027 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00976027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00976027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Year Efficacy Study of Fluzone High-Dose Trivalent Vaccine Compared With Fluzone® Vaccine In Adults ≥ 65 Years of Age
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2009
Completion date
April 30, 2012
Enrollment
9,172 (actual)
Sites
98

Conditions

As the registry lists them; a condition with its own page is linked.

influenza